Insider · CIK 0001267320
David L Porteous
director
Files at HBAN (HUNTINGTON BANCSHARES INC /MD/). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stock | +1,584 | $0.00 | $0 | 696,870 | 6 d ago |
| Oct 1, 2026 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: By IRA | +683 | $0.00 | $0 | 68,107 | 6 d ago |
| Oct 1, 2026 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: By SEP-IRA | +150 | $0.00 | $0 | 14,958 | 6 d ago |
| Oct 1, 2026 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: Director Deferred Compensation Plan | +1,143 | $0.00 | $0 | 111,209 | 6 d ago |
| Jan 2, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stock | +1,205 | $0.00 | $0 | 648,716 | Jan 6, 2025 |
| Jan 2, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: By IRA | +651 | $0.00 | $0 | 69,320 | Jan 6, 2025 |
| Jan 2, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: By SEP-IRA | +143 | $0.00 | $0 | 15,237 | Jan 6, 2025 |
| Jan 2, 2025 | HBAN HUNTINGTON BANCSHARES INC /MD/ | AGrant or award Common Stockindirect: Director Deferred Compensation Plan | +1,081 | $0.00 | $0 | 115,550 | Jan 6, 2025 |
| Nov 15, 2024 | HBAN HUNTINGTON BANCSHARES INC /MD/ | GGift Common Stock | -1,400 | $0.00 | $0 | 647,512 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.